| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.823 | 578 | 496 | 846 | 170 | 164 | 465 | 326 | 3.262 | 2.481 |
| Total Income - EUR | 20.982 | 578 | 496 | 846 | 170 | 164 | 465 | 326 | 3.262 | 2.481 |
| Total Expenses - EUR | 8.348 | 204 | 192 | 414 | 233 | 151 | 91 | 386 | 863 | 744 |
| Gross Profit/Loss - EUR | 12.634 | 374 | 304 | 431 | -63 | 13 | 374 | -60 | 2.399 | 1.738 |
| Net Profit/Loss - EUR | 12.004 | 356 | 289 | 406 | -68 | 8 | 359 | -70 | 2.009 | 1.456 |
| Employees | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Eta Grup Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.247 | 2.998 | 3.261 | 3.649 | 3.419 | 3.277 | 3.590 | 3.549 | 5.690 | 7.024 |
| Inventories | 1.793 | 1.775 | 1.745 | 1.504 | 1.475 | 1.447 | 1.415 | 1.419 | 1.415 | 905 |
| Receivables | 25 | 0 | 0 | 0 | 4 | 0 | 0 | 14 | 0 | 0 |
| Cash | 10.429 | 1.223 | 1.516 | 2.145 | 1.940 | 1.830 | 2.175 | 2.116 | 4.275 | 6.119 |
| Shareholders Funds | 11.837 | 2.720 | 2.964 | 3.315 | 3.182 | 3.130 | 3.420 | 3.361 | 5.360 | 6.786 |
| Social Capital | 81 | 80 | 79 | 77 | 76 | 74 | 73 | 73 | 73 | 72 |
| Debts | 410 | 278 | 297 | 334 | 237 | 147 | 170 | 189 | 330 | 238 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6310 - 6310" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Eta Grup Intermed Srl